Eramet S.a.
ERMAF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1,380,000 | $1,442,000 | $1,491,000 | $1,647,000 |
| % Growth | -4.3% | -3.3% | -9.5% | – |
| Cost of Goods Sold | $482,000 | $685,000 | $534,000 | $1,564,000 |
| Gross Profit | $898,000 | $757,000 | $957,000 | $83,000 |
| % Margin | 65.1% | 52.5% | 64.2% | 5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $805,000 | -$845,000 | $845,000 | $948,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $188,000 | $1,506,000 | $157,000 | -$1,003,000 |
| Operating Expenses | $993,000 | $661,000 | $1,002,000 | -$55,000 |
| Operating Income | -$95,000 | $96,000 | -$45,000 | -$49,000 |
| % Margin | -6.9% | 6.7% | -3% | -3% |
| Other Income/Exp. Net | -$39,000 | $78,000 | -$86,000 | $82,000 |
| Pre-Tax Income | -$134,000 | $174,000 | -$131,000 | $33,000 |
| Tax Expense | $45,000 | $33,000 | $61,000 | $73,000 |
| Net Income | -$152,000 | $55,000 | -$41,000 | $11,000 |
| % Margin | -11% | 3.8% | -2.7% | 0.7% |
| EPS | -5.31 | 1.93 | -1.44 | 0.39 |
| % Growth | -375.1% | 234% | -469.2% | – |
| EPS Diluted | -5.31 | 1.93 | -1.44 | 0.37 |
| Weighted Avg Shares Out | 28,625 | 28,472 | 28,472 | 28,493 |
| Weighted Avg Shares Out Dil | 28,625 | 28,472 | 28,472 | 30,041 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $37,000 | $12,691 | $58,000 |
| Interest Expense | $74,000 | $102,000 | $86,000 | $99,000 |
| Depreciation & Amortization | $115,000 | $145,000 | $93,000 | $125,000 |
| EBITDA | $21,000 | $230,000 | $30,000 | $177,000 |
| % Margin | 1.5% | 16% | 2% | 10.7% |